Announcement about the apponitment of Corporate
Governance Officer
Date of events
2022/08/04
To which item it meets
paragraph 8
Statement
1.Type of personnel changed (please enter: spokesperson, acting
spokesperson, important personnel (CEO, COO, CMO, CSO, etc.)
,financial officer, accounting officer, corporate governance officer,
chief information security officer, research and development officer,
chief internal auditor, or designated and non-designated representatives):
Corporate Governance Officer
2.Date of occurrence of the change:2022/08/04
3.Name, title, and resume of the previous position holder:Not applicable
4.Name, title, and resume of the new position holder:
Chou Cheng-Hsiao,the CFO of Excelsior Medical Co.,Ltd.
5.Type of the change (please enter: "resignation", "position
adjustment", "dismissal", "retirement", "death" or "new
replacement"):new appointment
6.Reason for the change:new appointment
7.Effective date:2022/09/01
8.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Excelsior Medical Co. Ltd. published this content on 04 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2022 09:36:02 UTC.
EXCELSIOR MEDICAL CO., LTD. is a Taiwan-based company principally engaged in the distribution, maintenance and leasing of medical equipment and supplies. The Companyâs principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The Company is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The Company mainly operates its businesses in domestic market and overseas markets.